SAG/ROC2/RBX2 E3 ligase promotes UVB-induced skin hyperplasia, but not skin tumors, by simultaneously targeting c-Jun/AP-1 and p27

Carcinogenesis

Volumn 29, Issue 4, 2008, Pages 858-865

  He, Hongbin ^a   Gu, Qingyang ^a   Zheng, Min ^a   Normolle, Daniel ^a   Sun, Yi ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; DNA; PROTEIN C FOS; PROTEIN C JUN; PROTEIN P27; PROTEIN P53; TRANSCRIPTION FACTOR AP 1; UBIQUITIN PROTEIN LIGASE E3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVITY; EPIDERMIS HYPERPLASIA; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN TARGETING; RADIATION CARCINOGENESIS; RADIATION EXPOSURE; SKIN CARCINOGENESIS; SKIN TUMOR; SKINFOLD THICKNESS; TRANSGENIC MOUSE; TUMOR PROMOTION; ULTRAVIOLET B RADIATION;

ANIMALS; CELL LINE; EPIDERMIS; HUMANS; HYPERPLASIA; IN SITU NICK-END LABELING; KERATINS; LUNG; MICE; MICE, TRANSGENIC; PROLIFERATING CELL NUCLEAR ANTIGEN; PROMOTER REGIONS (GENETICS); SKIN; SKIN NEOPLASMS; TRANSCRIPTION FACTOR AP-1; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION; ULTRAVIOLET RAYS;

EID: 41849091135     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn021     Document Type: Article

References (32)

1. Hanahan,D. et al. (2000) The hallmarks of cancer. Cell, 100, 57-70.
2. Epstein,J.H. (1983) Photocarcinogenesis, skin cancer, and aging. J. Am. Acad. Dermatol., 9, 487-502.
3. Einspahr,J.G. et al. (2003) Skin cancer chemoprevention: strategies to save our skin. Recent Results Cancer Res., 163 151-164; discussion 264-266.
4. Duan,H. et al. (1999) SAG, a novel zinc RING finger protein that protects cells from apoptosis induced by redox agents. Mol. Cell. Biol., 19, 3145-3155.
5. Kamura,T. et al. (1999) The Rbx1 subunit of SCF and VHL E3 ubiquitin ligase-activates Rub1 modification of cullins Cdc53 and Cul2. Genes Dev., 13, 2928-2933.
6. Ohta,T. et al. (1999) ROC1, a homolog of APC11, represents a family of cullin partners with an associated ubiquitin ligase activity. Mol. Cell, 3, 535-541.
7. Swaroop,M. et al. (2000) Yeast homolog of human SAG/ROC2/Rbx2/Hrt2 is essential for cell growth, but not for germination: Chip profiling implicates its role in cell cycle regulation. Oncogene, 19, 2855-2866.
8. Tan,P. et al. (1999) Recruitment of a ROC1-CUL1 ubiquitin ligase by Skp1 and HOS to catalyze the ubiquitination of IkBa. Mol. Cell, 3, 527-533.
9. Nakayama,K.I. et al. (2006) Ubiquitin ligases: Cell-cycle control and cancer. Nat. Rev. Cancer, 6, 369-381.
10. Sun,Y. (1999) Alteration of SAG mRNA in human cancer cell lines: requirement for the RING finger domain for apoptosis protection. Carcinogenesis, 20, 1899-1903.
11. Yang,G.Y. et al. (2001) Attenuation of ischemia-induced mouse brain injury by SAG, a redox- inducible antioxidant protein. J. Cereb. Blood Flow Metab., 21, 722-733.
12. Chanalaris,A. et al. (2003) SAG attenuates apoptotic cell death caused by simulated ischaemia/reoxygenation in rat cardiomyocytes. J. Mol. Cell. Cardiol., 35, 257-264.
13. Huang,Y. et al. (2001) Elevated expression of SAG/ROC2/Rbx2/Hrt2 in human colon carcinomas: SAG does not induce neoplastic transformation, but its antisense transfection inhibits tumor cell growth. Mol. Carcinog., 30, 62-70.
14. Sasaki,H. et al. (2001) Expression of the sensitive to apoptosis gene, SAG, as a prognostic marker in nonsmall cell lung cancer. Int. J. Cancer, 95, 375-377.
15. Duan,H. et al. (2001) Promotion of S-phase entry and cell growth under serum starvation by SAG/ROC2/Rbx2/Hrt2, an E3 ubiquitin ligase component: Association with inhibition of p27 accumulation. Mol. Carcinog., 30, 37-46.
16. Gu,Q. et al. (2007) SAG/ROC2/Rbx2 is a novel activator protein-1 target that promotes c-Jun degradation and inhibits 12-O-tetradecanoylphorbol-13-acetate-induced neoplastic transformation. Cancer Res., 67, 3616-3625.
17. Dlugosz,A.A. et al. (1995) Isolation and utilization of epidermal keratinocytes for oncogene research. Meth. Enzymol., 254, 3-20.
18. Quan,T. et al. (2002) Ultraviolet irradiation alters transforming growth factor beta/smad pathway in human skin in vivo. J. Invest. Dermatol., 119, 499-506.
19. Bockbrader,K.M. et al. (2005) A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells. Oncogene, 24, 7381-7388.
20. Cooper,S.J. et al. (2003) Expression of dominant negative c-jun inhibits ultraviolet B-induced squamous cell carcinoma number and size in an SKH-1 hairless mouse model. Mol. Cancer Res., 1, 848-854.
21. Rossiter,H. et al. (2001) Targeted expression of bcl-2 to murine basal epidermal keratinocytes results in paradoxical retardation of ultraviolet- and chemical-induced tumorigenesis. Cancer Res., 61, 3619-3626.
22. Xirodimas,D. et al. (2001) Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo. Oncogene, 20, 4972-4983.
23. Dhanalakshmi,S. et al. (2005) Silibinin up-regulates DNA-protein kinase-dependent p53 activation to enhance UVB-induced apoptosis in mouse epithelial JB6 cells. J. Biol. Chem., 280, 20375-20383.
24. Gu,Q. et al. (2007) SAG/ROC2 E3 ligase regulates skin carcinogenesis by stage dependent targeting of c-Jun/AP1 and IkB/NF-kB. J. Cell Biol., 178, 1009-1023.
25. Bian,J. et al. (1997) p53CP, a putative p53 competing protein that specifically binds to the consensus p53 DNA binding sites: A third member of the p53 family? Proc. Natl Acad. Sci. USA, 94, 14753-14758.
26. Jayaraman,J. et al. (1995) Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus. Cell, 81, 1021-1029.
27. kip1. J. Biol. Chem., 278, 28462-28469.
28. Lin,D.I. et al. (2006) Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alphaB crystallin) complex. Mol. Cell, 24, 355-366.
29. Haupt,Y. et al. (1997) Mdm2 promotes the rapid degradation of p53. Nature, 387, 296-299.
30. Sasaki,T. et al. (2006) Spatiotemporal regulation of c-Fos by ERK5 and the E3 ubiquitin ligase UBR1, and its biological role. Mol. Cell 24, 63-75.
31. Wu,K. et al. (2000) The SCF(HOS/beta-TRCP)-ROC1 E3 ubiquitin ligase utilizes two distinct domains within CUL1 for substrate targeting and ubiquitin ligation. Mol. Cell. Biol., 20, 1382-1393.
32. Zheng,N. et al. (2002) Structure of the Cull-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex. Nature, 416, 703-709.